PMO’s protective wrap: Unraveling its surfactant-mediated stabilization for next-generation antisense therapies

Read full text Summarise with VIRAT
Authors: Swrajit Nath Sharma, Abhishek Gupta, Surajit Sinha
Cited by: 0
References: 10

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

The rapid ascent of phosphorodiamidate morpholino oligonucleotides (PMOs) has fundamentally transformed the therapeutic landscape for rare genetic disorders such as Duchenne muscular dystrophy (DMD). At the vanguard of this revolution are the drug-like properties of PMOs, including high solubility, remarkable resistant to metabolic degradation, and a safer toxicity profile, which make them potent candidates for precision genetic medicine. Unlike traditional DNA and RNA therapeutics—defined by their negatively charged phosphate backbones—PMOs are uniquely charge-neutral.

Fields of Study & Subjects

RNA Interference and Gene Delivery DNA and Nucleic Acid Chemistry Nanoparticle-Based Drug Delivery

Publication details

Journal / source
Molecular Therapy — Nucleic Acids
Volume
37
Issue
2
Pages
102897–102897
Publication date
25 March 2026
Language
EN